Clinical Trial Update: Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating methenamine hippurate after intradetrusor onabotulinumtoxinA injections for overactive bladder, with recruitment not yet start…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Tract Infection

Drugs mentioned

• Methenamine Hippurate (Methenamine hippurate)
• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Overactive Bladder (OAB), Urinary Tract Infection (Diagnosis) | Phase 4 | Status: NOT_YET_RECRUITING